ALLO - Allogene Therapeutics, Inc. Common Stock

Allogene Therapeutics, Inc. (ALLO)

NGS · Common · CUSIP 019770106

Last Price•••.••

Current Yield•.••%

Yield to Call•.••%

Yield to Worst•.••%

Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ALLO and every other security on QuantumOnline.

Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒

🔒

Price chart and 15 days of daily prices

Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type: Common Stock
CUSIP: 019770106
Market Cap: Large Cap
IPO: 10/12/2018 · $18.00/share

Links: Home Page Investor Relations News

Business: Allogene Therapeutics, Inc. is a clinical stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) therapies for cancer.

Company Contact

CEO: Zachary Roberts
CFO: Eric Schmid
Headquarters: 210 East Grand Avenue, South San Francisco, CA 94080
Phone: 650-457-2700
Investor Relations: Christine Cassiano · 714-552-0326 · Christine.Cassiano@allogene.com
General Email: IR@allogene.com
Email Form: Contact Form »
SEC EDGAR Filings: View filings »